Merial granted full licensure for canine melanoma vaccine
http://vetmedicine.about.com/b/2010/01/11/merial-granted-full-licensure-for-canine-melanoma-vaccine.htmMonday January 11, 2010
The canine melanoma vaccine, ONCEPT (tm), by Merial, was granted a conditional license approval by the USDA in March 2007. Today, CNNMoney reported that the USDA has granted full licensure for this anti-tumor vaccine.
Merial confirmed the full license approval. The company plans to introduce ONCEPT(tm) in Orlando, Florida during the January 16 - 20 North American Veterinary Conference.
According to the Animal Medical Center in New York where clinical trials were performed:
"These dogs [in the trials] had a median survival time of 389 days, a dramatic increase in survival (most dogs with advanced malignant melanoma have a median survival time of only 60-90 days with presently available therapies). There has been no toxicity noted in any dogs receiving DNA melanoma vaccines to date." Read full report
